ArticleAmerican journal of translational research2025
The efficacy of exoskeletal-assisted walking for non-ambulatory patients with a spinal cord injury from T6 to L1 levels: a pre-post observational study.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo verify the efficacy of exoskeletal-assisted walking (EAW) on motor abilities and pulmonary performance of patients with a spinal cord injury (SCI) from T6 to L1 levels.
methodsAn observational pre-post prospective study was done with gait training with robotic exoskeletal devices in 117 patients (with age ≥ 18 years) who had complete or motor complete dorsal/dorso-lumber myelopathy.
resultsCompared to walking without the use of a robotic exoskeleton condition, all walking functions were improved 2-weeks and 1-week after the use of a robotic exoskeleton (
conclusionsEAW is a reliable method for the improvement of walking functions of patients suffering from SCI. The benefits of an EAW are over time connected to the usage of the exoskeleton.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.